Psychiatry and Neurology, Neurology · Temple, TX
NPI
1336455286
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2401 S 31st St
Temple, TX, 76508
Phone (254) 724-2111
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
787 services
Medicare patients, 2024
428
Average age 74
Drug cost, 2024
$1.7M
2,722 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad A Shawagfeh was code 99214 (office e&m - established), 524 times for 343 patients. In total Ahmad A Shawagfeh billed 787 services in 21 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 524 | 343 | $63.36 | $33K |
| 99204 Office E&M - New | Facility | 73 | 73 | $87.67 | $6,400 |
| 95983 Electrical Nerve Conductivity | Facility | 41 | 22 | $32.34 | $1,326 |
| 95874 Musculoskeletal | Facility | 34 | 15 | $12.40 | $421 |
By year: 2022 $62K for 941 services; 2023 $55K for 860 services; 2024 $49K for 787 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad A Shawagfeh prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 860 prescriptions and refills. In total Ahmad A Shawagfeh wrote 2,722 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 860 | 2,331 | 262 | $65K |
| Primidone Generic | 229 | 597 | 69 | $11K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 180 | 409 | 54 | $7,679 |
| Clonazepam Generic | 158 | 291 | 42 | $1,627 |
| Propranolol Hcl Generic | 118 | 298 | 37 | $4,596 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 105 | 248 | 29 | $12K |
| Ingrezza Valbenazine Tosylate | 97 | 97 | Under 11 | $767K |
| Gabapentin Generic | 96 | 262 | 28 | $3,443 |
| Rytary Carbidopa/Levodopa | 80 | 157 | 14 | $130K |
| Ropinirole Hcl Generic | 67 | 187 | 19 | $4,014 |
| Topiramate Generic | 61 | 168 | 19 | $1,157 |
| Amantadine Amantadine Hcl | 47 | 95 | 11 | $2,415 |
| Rasagiline Mesylate Generic | 38 | 100 | 12 | $9,886 |
| Austedo Deutetrabenazine | 37 | 37 | Under 11 | $387K |
| Gocovri Amantadine Hcl | 36 | 36 | Under 11 | $102K |
Brand drugs: 320 claims; generic drugs: 2,402 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ahmad A Shawagfeh were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.